Nautilus Biotechnology
Stock Forecast, Prediction & Price Target

Nautilus Biotechnology Financial Estimates

Nautilus Biotechnology Revenue Estimates

Nautilus Biotechnology EBITDA Estimates

Nautilus Biotechnology Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $11.99M
Low: $6.95M
High: $18.35M
avg. 0%
Avg: $38.73M
Low: $22.46M
High: $59.30M
avg. 223.05%
Avg: $63.4M
Low: $36.77M
High: $97.06M
avg. 63.66%
Avg: $94.5M
Low: $54.81M
High: $144.67M
avg. 49.05%
Net Income
 
% change YoY
$-50.31M
 
N/A
$-63.74M
 
-26.68%
$-63.67M
 
0.10%
Avg: $-105.03M
Low: $-109.92M
High: $-98.68M
avg. -64.95%
Avg: $-113.3M
Low: $-111.17M
High: $-98.68M
avg. -7.87%
Avg: $-98.68M
Low: $-166.80M
High: $-44.80M
avg. 12.89%
Avg: $-103.68M
Low: $-175.24M
High: $-47.07M
avg. -5.06%
EBITDA
 
% change YoY
$-47.65M
 
N/A
$-60.20M
 
-26.32%
$-74.30M
 
-23.42%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.6
 
N/A
-$0.51
 
14.99%
-$0.51
 
0%
Avg: -$0.82
Low: -$0.88
High: -$0.79
avg. -61.43%
Avg: -$0.84
Low: -$0.89
High: -$0.79
avg. -2.02%
Avg: -$0.79
Low: -$1.34
High: -$0.36
avg. 5.95%
Avg: -$0.83
Low: -$1.4
High: -$0.38
avg. -5.06%
Operating Expenses
 
% change YoY
$50.49M
 
N/A
$63.61M
 
25.98%
$76.15M
 
19.70%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Nautilus Biotechnology stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -16.24% in 2025-2028.

We have gathered data from 3 analysts. Their low estimate is -109.92M, average is -105.03M and high is -98.68M.

What is Nautilus Biotechnology stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 83.94% in 2025-2028.

We have gathered data from 3 analysts. Their low revenue estimate is $6.95M, average is $11.99M and high is $18.35M.

What is Nautilus Biotechnology stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -15.64% in 2025-2028.

We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.88, average is -$0.82 and high is $-0.79.

What is the best performing analyst?

In the last twelve months analysts have been covering Nautilus Biotechnology stock. The most successful analyst is Subbu Nambi.